Literature DB >> 17872527

Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.

Litao Yang1, Hui Peng1, Zhaoling Zhu1, Gang Li2, Zitong Huang3, Zhixin Zhao2, Richard A Koup4, Robert T Bailer4, Changyou Wu1.   

Abstract

The membrane (M) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is a major glycoprotein with multiple biological functions. In this study, we found that memory T cells against M protein were persistent in recovered SARS patients by detecting gamma interferon (IFN-gamma) production using ELISA and ELISpot assays. Flow cytometric analysis showed that both CD4+ and CD8+ T cells were involved in cellular responses to SARS-CoV M antigen. Furthermore, memory CD8+ T cells displayed an effector memory cell phenotype expressing CD45RO- CCR7- CD62L-. In contrast, the majority of IFN-gamma+ CD4+ T cells were central memory cells with the expression of CD45RO+ CCR7+ CD62L-. The epitope screening from 30 synthetic overlapping peptides that cover the entire SARS-CoV M protein identified four human T-cell immunodominant peptides, p21-44, p65-91, p117-140 and p200-220. All four immunodominant peptides could elicit cellular immunity with a predominance of CD8+ T-cell response. This data may have important implication for developing SARS vaccines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872527      PMCID: PMC2362397          DOI: 10.1099/vir.0.82839-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Lineage relationship and protective immunity of memory CD8 T cell subsets.

Authors:  E John Wherry; Volker Teichgräber; Todd C Becker; David Masopust; Susan M Kaech; Rustom Antia; Ulrich H von Andrian; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

2.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

3.  HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.

Authors:  Simone C Zimmerli; Alexandre Harari; Cristina Cellerai; Florence Vallelian; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-04       Impact factor: 11.205

4.  Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus.

Authors:  Yuxian He; Yusen Zhou; Pamela Siddiqui; Jinkui Niu; Shibo Jiang
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 5.  Functional diversity of helper T lymphocytes.

Authors:  A K Abbas; K M Murphy; A Sher
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

6.  Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells.

Authors:  M R Wills; A J Carmichael; M P Weekes; K Mynard; G Okecha; R Hicks; J G Sissons
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

7.  Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.

Authors:  Himani Bisht; Anjeanette Roberts; Leatrice Vogel; Alexander Bukreyev; Peter L Collins; Brian R Murphy; Kanta Subbarao; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

8.  Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.

Authors:  Kanta Subbarao; Josephine McAuliffe; Leatrice Vogel; Gary Fahle; Steven Fischer; Kathleen Tatti; Michelle Packard; Wun-Ju Shieh; Sherif Zaki; Brian Murphy
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Human memory T cell responses to SARS-CoV E protein.

Authors:  Hui Peng; Li-tao Yang; Jian Li; Zhi-qiang Lu; Ling-yun Wang; Richard A Koup; Robert T Bailer; Chang-you Wu
Journal:  Microbes Infect       Date:  2006-06-30       Impact factor: 2.700

10.  Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.

Authors:  Yan Zhi; Gary P Kobinger; Heather Jordan; Katie Suchma; Susan R Weiss; Hao Shen; Gregory Schumer; Guangping Gao; Julie L Boyer; Ronald G Crystal; James M Wilson
Journal:  Virology       Date:  2005-04-25       Impact factor: 3.616

View more
  29 in total

Review 1.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

2.  Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.

Authors:  Candice Clay; Nathan Donart; Ndingsa Fomukong; Jennifer B Knight; Wanli Lei; Lance Price; Fletcher Hahn; Jesse Van Westrienen; Kevin S Harrod
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

4.  Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.

Authors:  Jun Chen; Yuk Fai Lau; Elaine W Lamirande; Christopher D Paddock; Jeanine H Bartlett; Sherif R Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

5.  Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.

Authors:  Rudragouda Channappanavar; Craig Fett; Jincun Zhao; David K Meyerholz; Stanley Perlman
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

Review 6.  Understanding the T cell immune response in SARS coronavirus infection.

Authors:  Hsueh-Ling Janice Oh; Samuel Ken-En Gan; Antonio Bertoletti; Yee-Joo Tan
Journal:  Emerg Microbes Infect       Date:  2012-09-05       Impact factor: 7.163

Review 7.  T cell-mediated immune response to respiratory coronaviruses.

Authors:  Rudragouda Channappanavar; Jincun Zhao; Stanley Perlman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection.

Authors:  Yan-Ying Fan; Zi-Tong Huang; Li Li; Man-Hui Wu; Tao Yu; Richard A Koup; Robert T Bailer; Chang-You Wu
Journal:  Arch Virol       Date:  2009-06-13       Impact factor: 2.574

9.  Landscape and selection of vaccine epitopes in SARS-CoV-2.

Authors:  Christof C Smith; Kelly S Olsen; Benjamin G Vincent; Alex Rubinsteyn; Kaylee M Gentry; Maria Sambade; Wolfgang Beck; Jason Garness; Sarah Entwistle; Caryn Willis; Steven Vensko; Allison Woods; Misha Fini; Brandon Carpenter; Eric Routh; Julia Kodysh; Timothy O'Donnell; Carsten Haber; Kirsten Heiss; Volker Stadler; Erik Garrison; Adam M Sandor; Jenny P Y Ting; Jared Weiss; Krzysztof Krajewski; Oliver C Grant; Robert J Woods; Mark Heise
Journal:  Genome Med       Date:  2021-06-14       Impact factor: 15.266

10.  A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.

Authors:  Julie E Martin; Mark K Louder; LaSonji A Holman; Ingelise J Gordon; Mary E Enama; Brenda D Larkin; Charla A Andrews; Leatrice Vogel; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; Martha Nason; John R Mascola; Gary J Nabel; Barney S Graham
Journal:  Vaccine       Date:  2008-09-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.